Acting Chief Scientific Officer, Biologics · Cullinan Therapeutics, Inc. (CGEM)

Patrick Bauerle

A named executive officer of Cullinan Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$5,353,497

Salary $436,997Stock awards $491,284Bonus $266,131

FY2019: $562,797

2nd of 5 named executive officers at Cullinan Therapeutics by FY2020 total.

5 named officers on file for Cullinan Therapeutics, FY2020

Patrick Bauerle’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cullinan Therapeutics’s whole pay program stands against its peers

  • Cullinan Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CGEM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2021 (DEF 14A).

Free

Get Patrick Bauerle’s full pay file as a PDF — free

More than this page: up to 10 years of Patrick’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Patrick Bauerle compensation by year

Cullinan Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Cullinan Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$420,895$436,997
Bonus$107,502$266,131
Stock awards$0$491,284
Option awards$0$4,124,284
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$34,400$34,800
Total$562,797$5,353,497

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cullinan Therapeutics, Inc. DEF 14A filed April 29, 2021, accession 0001193125-21-140630, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cullinan Therapeutics, Inc. filed document, accession 0001193125-21-140630. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2021.

$563K
$5.4M
FY19
FY20
SalaryBonusStock awardsOption awardsAll other

Cullinan Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Owen HughesChief Executive Officer$6,552,058
Patrick Bauerle · this pageActing Chief Scientific Officer, Biologics$5,353,497
Patrick BaeuerleActing Chief Scientific Officer$5,353,496
Jon WiggintonChief Medical Officer$4,544,022
Jeffrey TrigilioChief Financial Officer$1,737,685

The full Cullinan Therapeutics compensation record

free company brief

This page is one person within Cullinan Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cullinan Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Patrick Bauerle's compensation dossier · One-time report. No refunds.